Joshua Ziel
Amministratore Delegato presso Aerami Therapeutics, Inc.
Posizioni attive di Joshua Ziel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Amministratore Delegato | 01/06/2023 | - |
| Direttore operativo | 01/06/2023 | - | |
| Corporate Officer/Principal | 01/01/2022 | 01/06/2023 |
Storia della carriera di Joshua Ziel
Formazione di Joshua Ziel
| Duke University | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Joshua Ziel
- Esperienza
